跳至主要内容
临床试验/NCT05223985
NCT05223985招募中不适用

EPISEEG - EPC Performance Investigation for StereoElectroEncephaloGraphy

Alcis2 个研究点 分布在 1 个国家目标入组 74 人开始时间: 2022年4月29日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
Alcis
入组人数
74
试验地点
2
主要终点
Signal quality

研究概览

简要总结

The objective of this multicentre study is to collect preoperative, intra operative, early, short, intermediate and mid-term(one years) on the related clinical complications and functional outcomes of market-approved Alcis products to demonstrate safety and performance of these devices in a real-world setting.

详细描述

Outcome data collected from this study will provide the basis for Post-Market Surveillance (PMS) reporting, Clinical Study Report (CSR), Clinical Evaluation Report (CER) on Alcis devices and support peer-reviewed publications on products performance and safety.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Months 至 65 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • To be included, patients must be:
  • 18 months to 65 years
  • Patient with drug-resistant and disabling focal epilepsy
  • Informed and willing to sign an informed consent form approved by EC / For minors: if one of the parents cannot consent within the timeframe provided by the protocol, then only one parent's signature is required
  • Affiliation to the social security or foreign regime recognized in France
  • For prospective inclusion: Patient considered for SEEG exploration as part of pre-surgical assessment of epilepsy
  • For ambispective inclusion:
  • Must have undergone an SEEG exploration with one ALCIS device before the date of the initiation visit
  • Follow-up visits (at least 12-month) must be prospective
  • Must have complete information available for each completed visit (demographics, preoperative information, implantation information, device details) *.

排除标准

  • • Not able to comply with the study procedures based on the judgment of the assessor (e.g. cannot comprehend study questions, inability to keep scheduled assessment times)
  • Any medical condition that could impact the study at investigator's discretion (e.g. allergy...)
  • Pregnant women (contraindication to SEEG exploration)
  • Adult subject to legal protection measure
  • Skull thickness inferior at 2 mm

结局指标

主要结局

Signal quality

时间窗: through study completion, an average of 10 days".

percentage of contacts that measured a signal

Modification of Electroencephalography trace post-coagulation

时间窗: through study completion, an average of 1 hours".

Modification of Electroencephalography trace post-coagulation

次要结局

未报告次要终点

研究者

发起方
Alcis
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

EPC Performance Investigation for... | 临床试验